Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Clareon PanOptix Pro vs. Clareon PanOptix - Study B

NCT: NCT06401551 · COMPLETED

NCT IDNCT06401551
StatusCOMPLETED
Start Date2024-06-18
Completion2025-04-30
SponsorAlcon Research (INDUSTRY)
First posted
Last updated

Brief Summary

The purpose of this study is to evaluate the safety and effectiveness of Clareon™ PanOptix™ Pro Trifocal Intraocular Lens (IOL) compared to Clareon™ PanOptix™ Trifocal IOL.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑